Research location
Armonk
New York, United States
Advertisement
Research activity in Armonk
New York, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 13 trials and 13 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Armonk
13 linked trials · page 1 of 1A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the LungNCT00998192 · 2009-10-01 · 1 site observation
COMPLETED
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung CancerNCT00738387 · 2008-12-01 · 1 site observation
TERMINATED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung CancerNCT00365183 · 2006-06-01 · 1 site observation
TERMINATED
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung CancerNCT00312377 · 2006-05-01 · 1 site observation
COMPLETED
Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerNCT00320710 · 2006-02-01 · 1 site observation
COMPLETED
Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerNCT00112346 · 2005-01-01 · 1 site observation
COMPLETED
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerNCT00399789 · 2004-09-01 · 1 site observation
COMPLETED
To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and OlderNCT00082095 · 2004-04-01 · 1 site observation
TERMINATED
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy RegimenNCT00069745 · 2003-09-01 · 1 site observation
COMPLETED
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerNCT00014222 · 2000-12-04 · 1 site observation
COMPLETED
Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung CancerNCT00035152 · 2000-06-01 · 1 site observation
COMPLETED
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT00080340 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.